摘要 |
A preventive and/or therapeutic agent for neutrophil inflammation disease, comprising as an active ingredient a substance capable of inhibiting the function relating to GPR4 signal transmission. In particular, a preventive and/or therapeutic agent for neutrophil inflammation disease, comprising a nitrogenous tricyclic compound of the formula (I): [wherein R<1> is a substituted or unsubstituted heterocyclic group, etc.; R<2> is hydrogen, a substituted or unsubstituted lower alkyl, etc.; each of R<3> and R<4> independently is hydrogen, a lower alkyl, etc.; n is 0 or 1; X is -(CH2)2-, etc.; and Y is represented by the formula: (A) (wherein W is CH or a nitrogen atom; each of Z<1> and Z<2> independently is hydrogen, a substituted or unsubstituted lower alkyl, etc.; and Z<3> is hydrogen, a substituted or unsubstituted lower alkyl, etc.)], or a quaternary ammonium salt of the same or a pharmacologically acceptable salt thereof.
|
申请人 |
KYOWA HAKKO KOGYO CO. LTD.;SAKI, MAYUMI;NONAKA, HIROMI;MIYAJI, HIROMASA;TAKAHASHI, CHISA;MANABE, HARUHIKO;HIURA, NAOKO;MIKI, ICHIRO;ABE, YUZURU;SASAKI, KATSUTOSHI;KOBATAKE, CHOEI;ICHIKAWA, SHUNJI;GOTO, AKIHISA;SUDA, TOSHIO |
发明人 |
SAKI, MAYUMI;NONAKA, HIROMI;MIYAJI, HIROMASA;TAKAHASHI, CHISA;MANABE, HARUHIKO;HIURA, NAOKO;MIKI, ICHIRO;ABE, YUZURU;SASAKI, KATSUTOSHI;KOBATAKE, CHOEI;ICHIKAWA, SHUNJI;GOTO, AKIHISA;SUDA, TOSHIO |